Molecularly targeted drugs for metastatic colorectal cancer
Ying-dong Cheng, Hua Yang, Guo-qing Chen, Zhi-cao Zhang Department of General Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China Abstract: The survival rate of patients with metastatic colorectal cancer (mCRC) has significantly improved with a...
Saved in:
Main Authors: | Cheng YD (Author), Yang H (Author), Chen GQ (Author), Zhang ZC (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches
by: Furong Li, et al.
Published: (2023) -
Targeting metastatic colorectal cancer – present and emerging treatment options
by: Ciombor KK, et al.
Published: (2014) -
Progress of research on molecular targeted therapies for colorectal cancer
by: Shilin Huang, et al.
Published: (2023) -
Up-and-Coming Experimental Drug Options for Metastatic Colorectal Cancer
by: Cimino SK, et al.
Published: (2020) -
METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY
by: N. A. Avxentyev, et al.
Published: (2016)